The ability of virus-specific CD8
INTRODUCTION
Cytokines play a pivotal role in regulating any type of adaptive immune response, and T cells are an important source of cytokines in the context of both primary and memory immune responses. It is normally assumed that CD4 + T cells are the main cytokine-producing T cell subset, and much research in this field has been focused around the division of these cells into T H 1 (IL-2, IFN-c and TNF-a) and T H 2 (IL-4, IL-5, IL-6 and IL-10) cells based on their cytokine profile, and the mechanisms regulating this differentiation (Mosmann et al., 1986; Mosmann & Sad, 1996; Liew, 2002) . In contrast, CD8
+ T cells have traditionally been regarded as a homogeneous subset of cytolytic cells, and their potential for production of cytokines is often neglected. For this reason much of the research on antiviral CD8
+ T cell responses has centred on the cytolytic abilities of these cells (Lukacher et al., 1984; Binder & Kundig, 1991; Kagi et al., 1994) , proving cell killing to be an essential effector mechanism required for the control of many, but not all viral infections (Kagi & Hengartner, 1996) . However, studies of long-term CD8 + T cell clones/lines revealed years ago that like CD4 + T cells, CD8 + T cells also have the potential to produce a wide variety of cytokines (Paliard et al., 1988) . However, the relevance of this during in vivo immune responses was not investigated (Kelso et al., 1982; Morris et al., 1982; Prystowsky et al., 1982) . Supporting a role for CD8 + T cells as cytokine producers, fresh human CD8 + T cells treated with either PMA/ ionomycin or plate-bound a-CD3 antibody have recently been found to produce a number of cytokines and chemokines (Conlon et al., 1995) . Together, these observations suggest that CD8 + T cells could be relevant producers of many cytokines in vivo. Based on these and more recent experiments aimed at studying CD8 + T cell effector cell differentiation in vitro, it has been suggested that activated CD8 + T cells can also be divided into two functionally distinct subsets producing either the T H 1 or T H 2 types of cytokines; by analogy to their CD4 + counterparts these subsets have been named T C 1 and T C 2 cells, respectively (Croft et al., 1994; Maggi et al., 1994; Le Gros & Erard, 1994; Sad et al., 1995) . Existing data also suggest that these phenotypes are relatively stable: in vitro-generated effector CD8
+ T cells of either T C 1 or T C 2 phenotype have been shown to survive in vivo for at least 90 days after adoptive transfer and still maintain their characteristic cytokine profile (Cerwenka et al., 1998) . However, whether a similar stability applies to in vivo-activated polyclonal CD8 + T cells is presently unknown.
Despite the fact that it is becoming increasingly evident that CD8 + T cells may be relevant as producers of cytokines, there are still a number of questions that need to be addressed. What is the range of cytokines -at the population level as well as at the level of the individual cellwhich may be produced by in vivo-primed antigen-specific CD8 + T cells? Is this profile fixed or does it change as a function of time and the state of activation (effectorR memory cell)? How do cytokine-producing CD8 + T cells compare qualitatively and quantitatively to antigen-specific CD4 T cells primed in parallel? The primary aim of this study was therefore to determine the ability of virus-specific CD8 + T cells to produce cytokines as a function of their activation state, and to define some of the parameters influencing the spectrum of cytokines produced. Cells were analysed ex vivo using primarily intracellular staining for cytokines and flow cytometry. This type of analysis makes it possible not only to determine the spectrum of cytokines, which can be produced at the population level, but also allows a precise evaluation of the number of cells involved as well as the relationship between subset of cells producing different cytokines.
METHODS
Mice. Female BALB/cJ and C57BL/6 (B6) mice were purchased from M & B (Ry, Denmark). RAG-2-deficient mice expressing a transgenic TCR for np [52] [53] [54] [55] [56] [57] [58] [59] + T cells were the progeny of breeding pairs kindly provided by H. Pircher and R. M. Zinkernagel, University of Zürich, Switzerland (Pircher et al., 1989) . IFN-c deficient mice (IFN-c 2/2 ) and IL-12b deficient mice (IL-12b 2/2 ), both on a C57BL/6 background, were obtained from Jackson Laboratory (Bar Harbour, ME, USA). Mice from outside sources were always allowed to rest for at least 1 week before entering into experiments, at which time the animals usually were 7-9 weeks old. Animals were housed under specific pathogen-free conditions, and all experiments were conducted in compliance with national regulations.
Viruses and virus infections. The viscerotropic Traub strain of LCMV was administered i.v. or i.p. in a dose of approx. 200 p.f.u.; inoculation by these routes results in non-lethal, immunizing infection . VSV of the Indiana strain was used in a dose of 10 6 p.f.u. i.v. This dose is non-lethal in immunocompetent mice, but induces a potent CD8 + T cell response (Andreasen et al., 2000) . For co-infection experiments (VSV and LCMV) the less invasive LCMV strain (Armstrong clone 53b) was used; this strain was used in a dose of 5000 p.f.u. i.v. All viruses were produced, stored and quantified as described before (Marker & Volkert, 1973; Thomsen et al., 1997) .
Cell preparation. Spleens were removed from mice killed by cervical dislocation. Single-cell suspensions of spleen cells were obtained by pressing the organs through a fine steel mesh. Peritoneal cells were obtained by lavage with 5 ml of ice-cold Hanks' balanced salts solution. [52] [53] [54] [55] [56] [57] [58] [59] ). After stimulation the cells were stained with relevant antibodies as described previously . For tetramer staining, cells were incubated with tetramers for 30 min at 4 uC, at which time mAbs for surface labelling were added; the cells were then incubated for a further 30 min at 4 uC, before washing and fixation (Christensen et al., 2001) . Sample data were acquired using a FACSCalibur (BD Biosciences), and results were analysed using CellQuest software (BD Biosciences). Isotype control mAbs and in some cases also unstimulated cells were included to define appropriate cut-off levels.
Quantification of chemokine production. Supernatants harvested from peptide (1 mg ml 21 ) and unstimulated cultures of splenic cells incubated for 6 h in vitro were assayed for chemotactic cytokines using commercially available sandwich ELISA kits (R&D systems).
RESULTS

LCMV-specific cytokine-producing CD8
+ T cells outnumber CD4 + T cells both during the primary immune response and in the memory phase
To determine the range of cytokines produced by a polyclonal population of virus-specific CD8 + T cells, B6 mice were infected i.v. with LCMV of the Traub strain, and cytokine production by CD8 + T cells specific to the class I-restricted viral peptide gp 33-41 (an immunodominant epitope in H-2 b mice) was determined by staining for intracellular cytokine or -in the case of chemokines -by ELISA. For comparison cytokine production by CD4 + T cells specific to the class II-restricted viral peptide gp [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] (immunodominant epitope in H-2 b ) was analysed in parallel.
As shown previously (Butz & Bevan, 1998; Murali-Krishna et al., 1998; Slifka & Whitton, 2000; Varga & Welsh, 2000; Kristensen et al., 2002) , primary virus-specific CD4
+ and CD8
+ effector T cells produce the cytokines IFN-c, TNF-a and IL-2 (Fig. 1A) . A substantial subset of primary effector T cells also produced GM-CSF. Besides producing proinflammatory cytokines, MHC class I-restricted T cells were also found to be the predominant source of the chemotactic cytokines RANTES, MIP (macrophage inflammatory protein)-1a and b (Fig. 2) . In contrast, T cells producing type 2 cytokines (IL-4, IL-5 and IL-10) or IL-3 were either absent or found at marginal frequencies within both T cell compartments ( Fig. 1B and C and data not shown).
With progression towards the memory state a higher proportion of antigen-specific CD8 + T cells produce TNF-a and IL-2 (Fig. 1B) . Interestingly, the kinetics of GM-CSFproducing cells is different. In the acute phase [day 9-11 post infection (p.i.)] the number of GM-CSF-producing CD8 + T cells make up 25-30 % of the number of IFN-cproducing cells and exceed the number of IL-2-producing cells. However, during the contraction phase there is a preferential loss of GM-CSF-producing CD8 + T cells, and the ratio of IL-2-to GM-CSF-producing cells is inverted 28 and 70 days after infection (Fig. 1B) .
It should be noted that although both virus-specific CD4 + and CD8
+ T cells are clearly type 1 cells, the distribution of cytokine-producing subsets differs. Similar numbers of CD4 + T cells produce TNF-a, IL-2 or GM-CSF during the primary response whereas TNF-a-producing cells are more prevalent amongst CD8
+ effector T cells. Following contraction of the T cell population, equal numbers of IFNc-, TNF-a-and IL-2-producing CD4 + T cells were observed (Fig. 1C) . As with CD8
+ T cells, GM-CSF-producing cells were less prevalent in the memory phase.
Virus-specific CD8
+ T cells producing TNF-a, GM-CSF or IL-2 constitute overlapping subpopulations of cells also producing IFN-c
To study the relationship between CD8
+ T cells producing different cytokines, gp 33-41 stimulated CD8
+ effector T cells were co-stained for two of the following cytokines: IFN-c, TNF-a, GM-CSF and IL-2 (Fig. 3) .
Confirming earlier observations (Slifka & Whitton, 2000; Kristensen et al., 2002) , we found that TNF-a and IL-2 are produced by cells, which also synthesize high amounts of IFN-c; a similar pattern was found for GM-CSFproducing cells (Fig. 3, upper panel) . With regard to coproduction of the less frequently produced cytokines, TNF-a, GM-CSF and IL-2, a more heterogeneous pattern was observed (Fig. 3, lower panel) . However, statistical analysis revealed that all pairs of cytokines were coexpressed at frequencies higher than expected by chance (P<0?05; x 2 contingency table testing) indicating that the ability to produce these cytokines is partially linked.
Cytokine profile of virus-specific CD8
+ T cells generated during primary VSV infection To investigate whether the same cytokines would be produced by virus-specific CD8 + T cells generated in response to another virus, B6 mice were inoculated i.v. with VSV. Infectious VSV can only be isolated briefly from the spleen, and this CD8 T cell response therefore represents programmed expansion and differentiation of cells in the absence of actual infection. On day 7 (the peak of the primary response) and day 21 (memory state) after infection, we analysed the capacity of np 52-59 specific (immunodominant epitope in H-2 b mice) CD8 + T cells to produce cytokines (Fig. 4) .
Except for a failure to produce GM-CSF, VSV-specific CD8 + T cells produced the same range of cytokines as did LCMV-specific cells, and virus-specific CD8 + T cells producing the cytokines IL-4, IL-5 and IL-10 were not detected in either case (data not shown). Interestingly, at the peak of the primary response, TNF-a-producing cells made up only about one-fifth to one-third of IFN-cproducing VSV-specific cells compared with ¢one-half of primary LCMV-specific cells. Furthermore, both these cytokines was produced at a lower level by VSV-specific cells compared with LCMV-specific cells (Fig. 4B) .
Cytokine phenotype of virus-specific CD8
+
T cells as a function of localization
Besides splenic T cells, we evaluated the ability of LCMVand VSV-specific CD8 + T cells from the peritoneum to Six hours later culture supernatants were harvested, and chemokine levels were quantified using sandwich ELISAs. Means of three wells stimulated in parallel is presented (SDs were too small to be depicted).
produce cytokines (Table 1 and 2). The peritoneum represents a tertiary organ site, and the cells present here are likely to represent a more differentiated phenotype compared with cells obtained from secondary lymphoid tissues (Masopust et al., 2001 ).
Ten days after LCMV infection i.p., at the peak of the local inflammatory response, we found ( Table 1 ) that while the frequency of IFN-c-producing cells was only slightly increased in peritoneum, the frequencies of TNF-a-, GM-CSF-and IL-2-producing cells were all markedly (2-to 3-fold) higher in this site compared to the spleen. As TNF-a, GM-CSF and IL-2 in both organ sites were produced by cells, which also synthesized IFN-c (Fig. 3 and data not shown), this pattern suggested that co-producing cells are preferentially attracted to and/or sustained in tertiary organ sites. However, since i.p. inoculation of LCMV results in peritonitis, the explanation could also be that virus-specific CD8 + T cells locally receive inflammatory signals, which may influence their differentiation/maturation.
To investigate whether such signals were essential, we analysed virus-specific cells harvested from the peritoneum of mice infected with VSV i.v.; in this case no inflammatory response is observed (no increase in cell numbers).
At the height of the primary response to VSV, not only the frequency of IFN-c producers (Table 2) , but also the level of per-cell expression was significantly higher for peritoneal cells than for splenocytes (data not shown). In addition, the ratio of cytokine + /tetramer (tet) + cells was significantly higher in peritoneum, and, as in LCMV-infected mice, a higher frequency of peritoneal CD8 + T cells produced more than one cytokine (all TNF-a-producing cells also produced IFN-c) ( Table 2 ). Twenty one days after infection the majority of VSV-specific (tet + ) CD8 + T cells both in the spleen and in the peritoneum produced IFN-c. About half the virus-specific CD8 + T cells in the spleen were also TNF-a + whereas nearly all virus-specific CD8 + T cells harvested from the peritoneum co-produced TNF-a. Thus, the proportion of co-producing cells increased with time in both spleen and peritoneum. Moreover, cells with this phenotype were found at a higher frequency in the peritoneum independently of local inflammatory signals (Table 2) .
Co-infection with LCMV augments the VSV-specific CD8 + T cell response, but does not induce GM-CSF production
The state of the APC is known to critically influence T cell differentiation. To see whether the cytokine production by VSV-specific CD8 + T cells would be affected if the APCs simultaneously were activated by LCMV, B6 mice were coinfected with LCMV and VSV (there is no cross-reactivity between the two viruses) (Andreasen et al., 2000) , and on day 7 after infection the number of cytokine-producing cells in the spleen was determined using intracellular staining and FACS analysis (Fig. 5) . In co-infected mice the number of splenic VSV-specific CD8 + T cells producing IFN-c and in particular TNF-a was significantly increased (2?6-and 3?2-fold, respectively). Furthermore, per-cell expression of both cytokines was also increased (not shown) so that the fluorescence distribution of cytokineproducing specific cells resembled that seen in LCMVinfected mice (cf. Fig. 4 ). Together these findings strongly indicate that signals induced during LCMV infection are able to augment the generation/differentiation of VSVspecific CD8
+ effector T cells. However, the latter cells did not begin to produce GM-CSF indicating that other regulatory mechanisms control this differentiation. DRatio of cytokine-producing cells within the CD8 + T cell subset. DRatio between TNF-a-and IFN-c-positive CD8 + T cells. 
Heterogeneity in cytokine production by virus-specific CD8
+ T cells does not require TCR diversity
The degree of TCR occupancy required for activation of different effector responses is known to vary (Valitutti et al., 1996; Itoh & Germain, 1997) . The heterogeneity in cytokine phenotypes induced during an antiviral CD8 + T cell response could therefore reflect the range of avidities found for a normal, polyclonal response involving a spectrum of TCR clonotypes. To test this assumption, we analysed the cytokine production from in vivo activated T cells expressing a single TCR clonotype.
Naive B6 mice were given spleen cells from TCR transgenic mice (TCR-318) expressing a Va2/Vb8?2 T cell receptor specific for LCMV gp [33] [34] [35] [36] [37] [38] [39] [40] [41] . The day after cell transfer, recipients were infected with LCMV, and 9 days after infection TCR + CD8 + T cells were analysed for the ability to produce cytokines (Fig. 6) . Despite the uniform expression of a single clonotype, in vivo activated TCR + cells not only produced the same spectrum of cytokines (IFN-c, TNF-a, IL-2 and GM-CSF) (Fig. 6) as did gp 33-41 -specific cells from normal mice (see Fig. 1 for comparison) , but the distribution of cytokine-producing cells also matched that observed for polyclonal cells with the same specificity.
In parallel experiments naive B6 mice were given TCR transgenic cells specific for VSV np [52] [53] [54] [55] [56] [57] [58] [59] , and recipients were subsequently infected with VSV. Again the cytokine profile of in vivo-activated TCR + cells (Fig. 6 ) mimicked that of polyclonal cells with the same specificity (in this case TCR + cells were only recovered from half the transplanted recipients, possible due to incompatibilities at minor histocompatibility loci, but the pattern observed in all animals in which the TCR transgenic cells had expanded was highly reproducible). Together these observations strongly indicate that the normal diversity in TCR avidity is not the explanation for the cellular heterogeneity in cytokine production.
IFN-c and IL-12 is not required to inhibit the generation of T C 2 cells during primary VSV infection
From in vitro studies it is known that CD8 + T cells cultured with antigen in the presence of anti-IFN-c (and IL-4) will develop a T H 2 like phenotype (T C 2 cells) (Croft et al., 1994; Sad et al., 1995) . To see if T C 2 cells would be generated in vivo in the absence of IFN-c, IFN-c 2/2 mice were infected with VSV (failure to the produce IFN-c does not influence the course of VSV infection) (Andersen et al., 1999) , and on day 7 p.i. we looked for np [52] [53] [54] [55] [56] [57] [58] [59] 
DISCUSSION
In this report we have studied the ability of in vivo-primed virus-specific CD8 + T cells to produce cytokines directly ex vivo. At the peak of the primary response CD8 + T cells have the ability to produce a broad spectrum of cytokines: IFN-c, TNF-a, IL-2, GM-CSF, RANTES, MIP-1a and b. Since CD8 + T cells appear to be pre-programmed to undergo much more extensive proliferation and to be sustained at a higher level than CD4 + T cells (Christensen et al., 1996a, b; Homann et al., 2001; Foulds et al., 2002) , our analysis strongly suggests that CD8 + T cells are the major source of T-cell derived cytokines throughout most viral infections. Certainly, our results readily explain why CD4 + T cells are not essential for LCMV-induced T cell-mediated inflammation (Marker et al., 1995) .
CD8
+ T cells can be divided into T C 1 and T C 2 subsets producing the same range of cytokines as the corresponding T H subsets (Croft et al., 1994; Maggi et al., 1994; Le Gros & Erard, 1994; Sad et al., 1995) . However, virus-specific CD8 + T cells seem to have a strong propensity to develop a T C 1 cytokine profile: IL-4-, IL-5-and IL-10-producing cells were not found in either LCMV-infected B6 or BALB/c (data not shown) mice or following VSV infection. IFN-c and IL-12 is known to regulate the in vitro differentiation of CD8 + T cells into a type 1 cytokine-producing phenotype. However, similar to the situation for T H cells (Schijns et al., 1994; Oxenius et al., 1999) , we did not find type 2 T C cells in IFN-c or IL-12b deficient mice. Notably, this type 1 profile was observed even following inoculation of a virus (VSV), which undergo very limited replication in the host (no infectious VSV can be detected in spleen beyond day 2 p.i.). Taken together these observations suggest that CD8 + T cells intrinsically are hardwired towards type 1 differentiation. Consistent with this assumption, and unlike the situation for CD4 + T cells, very few instances of in vivogenerated type 2 CD8 + T cells have been described (Salgame et al., 1991; Maggi et al., 1994) .
Virtually all virus-specific CD8
+ T cells generated during primary LCMV infection produce IFN-c (Butz & Bevan, 1998; Murali-Krishna et al., 1998) . Part of these cells also produce TNF-a and IL-2 (Slifka & Whitton, 2000; Kristensen et al., 2002) . Here, we extend these observations by showing that a subpopulation of IFN-c-producing CD8 + T cells may also produce GM-CSF. More important, we find that although virus-specific CD8 + T cells are quite heterogeneous in their ability to produce cytokines, the ability to produce more than one cytokine is not a random occurrence. Indeed there is a significant trend for co-production of several cytokines. The frequency of coproducing cells was significantly higher in the peritoneum than in the spleen independently of local inflammatory signals. This may indicate that co-producing CD8 + T cells are to be found mainly among fully differentiated cells with the potential to leave the secondary lymphoid organs and migrate into tertiary tissues. Notably, there also seems to be a preferential survival of these multipurpose cells as the relative frequency of this phenotype increases following contraction of the CD8 + T cell population. These observations expand on existing data (Slifka & Whitton, 2000; Kristensen et al., 2002) suggesting that there is a preferential maintenance of a T cell phenotype characterized by the potential to produce several cytokines. Interestingly, the ability to produce all cytokines is not maintained; LCMV-specific CD8 + T cells producing GM-CSF are only abundant during the effector phase and preferentially disappear with transition into the memory phase.
Interestingly, few GM-CSF-producing cells are generated during VSV infection, and overall VSV-specific CD8 + T cells appear to be less functionally differentiated during the primary response than do LCMV-specific cells: while the ratio of IFN-c + /tet + is close to one for LCMV at the time of peak effector cell numbers (Butz & Bevan, 1998; Murali-Krishna et al., 1998) , this ratio is only about 1 : 2 in VSV infected mice (present report). Furthermore, per-cell IFN-c production is lower [lower mean fluorescence intensity (MFI)], and fewer VSV-specific, IFN-c + CD8
+ T cells co-produce TNF-a. With time these differences tend to diminish. One explanation for this pattern could be that during acute VSV infection, many antigen-specific CD8 + T cells are generated, which are arrested at an early stage of differentiation and therefore preferentially lost during the contraction phase. Part of the reason why functional differentiation may be less complete following VSV infection as compared with LCMV infection, could be a difference in the state of the APCs during the two infections (Ruedl et al., 1999) . Consistent with this assumption we find that numbers and per-cell capacity of VSV-specific cells to produce IFN-c and TNF-a increase in co-infected animals. However, no induction of GM-CSF-producing cells was observed, indicating that additional factors influence cytokine production -perhaps the transient nature of antigen presentation in VSV infected mice (Andreasen et al., 2000; Christensen et al., 2002) also plays a role. Supporting that the environment in which antigen presentation takes place may influence the overall cytokine profile, we found that naive TCR + cells specific for immunodominant epitopes of either virus differentiate into cytokine-expression patterns which reproduce the differences seen for polyclonal cells of the same specificity (cf. production of TNF-a and GM-CSF).
From other studies it appears that different thresholds exist for induction of different cytokines (Valitutti et al., 1996; Itoh & Germain, 1997) . Thus, a likely assumption would be that much of the heterogeneity in cytokine production by cells with the same epitope specificity reflected the normal diversity of the involved TCRs, i.e. cells with high avidity for their antigen might be activated to produce a wider range of cytokines than low avidity cells. However, in vivo-primed TCR transgenic cells were as heterogeneous in their cytokine profile as were a normal polyclonal T cell population with the same epitope specificity. Thus, a diverse avidity spectrum does not suffice to explain the heterogeneity in cytokine phenotypes. This conclusion is consistent with previous findings demonstrating intraclonal heterogeneity in cytokine production by long-term CD4 + T cells in culture (Itoh & Germain, 1997 ).
In conclusion, our results underscore the extensive range of cytokines that may be produced by in vivo activated CD8 + T cells. Interestingly, almost similar cytokine profiles are generated whether or not extensive virus replication takes place. This may suggest a deeply founded propensity of CD8 + T cells for type 1 differentiation, which may be linked to their evolutionary role as effector cells controlling parasites with a cytoplasmic habitat.
